Michael Boezer serves as Welldoc’s Chief Financial Officer, bringing more than 25 years of distinguished leadership across healthcare and technology-enabled industries. He has a track record of unlocking step-change growth in enterprise value by driving optimal capital deployment and financial rigor.
Michael’s expertise is instrumental in scaling Welldoc’s pioneering digital health solutions, supporting the company’s revolution in cardiometabolic health. Prior to joining Welldoc, he was CFO of Flagship Biosciences. His extensive executive tenure includes successfully leading key financial efforts during the IPO of Inovalon, a successful PE recapitalization at Custom Ink, and a nine-year tenure at Pfizer. His foresight continues to position Welldoc for accelerated growth and sustained enterprise value.
